Baillie Gifford & CO Schrodinger, Inc. Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Schrodinger, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 1,980,992 shares of SDGR stock, worth $38.5 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,980,992
Previous 2,124,968
6.78%
Holding current value
$38.5 Million
Previous $41.1 Million
10.58%
% of portfolio
0.03%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding SDGR
# of Institutions
235Shares Held
60.7MCall Options Held
726KPut Options Held
329K-
Black Rock Inc. New York, NY8.52MShares$166 Million0.0% of portfolio
-
Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$136 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.71MShares$130 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.69MShares$71.6 Million1.9% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.34MShares$45.4 Million0.41% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.21B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...